Fibrocell Science Stock Price, News & Analysis (NASDAQ:FCSC)

$0.67 -0.02 (-2.90 %)
(As of 12/12/2017 04:48 AM ET)
Previous Close$0.69
Today's Range$0.61 - $0.70
52-Week Range$0.61 - $4.64
Volume817,000 shs
Average Volume114,804 shs
Market Capitalization$10.23 million
P/E RatioN/A
Dividend YieldN/A
Beta0.33

About Fibrocell Science (NASDAQ:FCSC)

Fibrocell Science logoFibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either idiopathic or age-related. It is investigating the indication in a Phase II clinical trial. Its gene-therapy product candidate, FCX-007, is in pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Its gene-therapy product candidate, FCX-013, is in pre-clinical development for the treatment of linear scleroderma. Its product, LAVIV (azficel-T), is indicated for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. A third gene-therapy program is focused on the treatment of arthritis. Its product, LAVIV (azficel-T), is focused on improving the appearance of nasolabial fold wrinkles in adults.

Receive FCSC News and Ratings via Email

Sign-up to receive the latest news and ratings for FCSC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:FCSC
CUSIPN/A
Phone484-713-6000

Debt

Debt-to-Equity RatioN/A
Current Ratio3.52%
Quick Ratio3.52%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$350,000.00
Price / Sales28.18
Cash FlowN/A
Price / CashN/A
Book Value$0.54 per share
Price / Book1.24

Profitability

Trailing EPS($1.83)
Net Income$-15,290,000.00
Net MarginsN/A
Return on Equity-640.52%
Return on Assets-100.12%

Miscellaneous

Employees23
Outstanding Shares14,720,000

Fibrocell Science (NASDAQ:FCSC) Frequently Asked Questions

What is Fibrocell Science's stock symbol?

Fibrocell Science trades on the NASDAQ under the ticker symbol "FCSC."

How were Fibrocell Science's earnings last quarter?

Fibrocell Science Inc (NASDAQ:FCSC) posted its quarterly earnings results on Thursday, November, 3rd. The company reported ($0.05) EPS for the quarter, beating the Zacks' consensus estimate of ($0.15) by $0.10. The firm had revenue of $0.22 million for the quarter, compared to the consensus estimate of $0.07 million. View Fibrocell Science's Earnings History.

When will Fibrocell Science make its next earnings announcement?

Fibrocell Science is scheduled to release their next quarterly earnings announcement on Thursday, March, 8th 2018. View Earnings Estimates for Fibrocell Science.

Where is Fibrocell Science's stock going? Where will Fibrocell Science's stock price be in 2017?

3 analysts have issued 12 month target prices for Fibrocell Science's shares. Their forecasts range from $2.00 to $7.60. On average, they anticipate Fibrocell Science's share price to reach $5.53 in the next twelve months. View Analyst Ratings for Fibrocell Science.

Are investors shorting Fibrocell Science?

Fibrocell Science saw a increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,083,658 shares, an increase of 43.3% from the October 31st total of 756,335 shares. Based on an average daily trading volume, of 116,142 shares, the short-interest ratio is presently 9.3 days. Approximately 11.9% of the shares of the stock are sold short.

Who are some of Fibrocell Science's key competitors?

Who are Fibrocell Science's key executives?

Fibrocell Science's management team includes the folowing people:

  • Douglas J. Swirsky, Chairman of the Board
  • John M. Maslowski, President, Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer
  • Lisa A. Embon, Vice President - of Corporate Accounting , Controller
  • , Bio & Compensation - 
  • Kelvin Moore, Lead Independent Director
  • Julian P. Kirk, Director
  • Marcus E. Smith, Director
  • Marc B. Mazur, Independent Director
  • Christine Thompson St.Clare, Independent Director

Who owns Fibrocell Science stock?

Fibrocell Science's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Pura Vida Investments LLC (2.02%). View Institutional Ownership Trends for Fibrocell Science.

Who bought Fibrocell Science stock? Who is buying Fibrocell Science stock?

Fibrocell Science's stock was bought by a variety of institutional investors in the last quarter, including Pura Vida Investments LLC. View Insider Buying and Selling for Fibrocell Science.

How do I buy Fibrocell Science stock?

Shares of Fibrocell Science can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fibrocell Science's stock price today?

One share of Fibrocell Science stock can currently be purchased for approximately $0.67.

How big of a company is Fibrocell Science?

Fibrocell Science has a market capitalization of $10.23 million and generates $350,000.00 in revenue each year. The company earns $-15,290,000.00 in net income (profit) each year or ($1.83) on an earnings per share basis. Fibrocell Science employs 23 workers across the globe.

How can I contact Fibrocell Science?

Fibrocell Science's mailing address is 405 EAGLEVIEW BOULEVARD, EXTON PA, 19341. The company can be reached via phone at 484-713-6000 or via email at [email protected]


MarketBeat Community Rating for Fibrocell Science (FCSC)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  97 (Vote Underperform)
Total Votes:  220
MarketBeat's community ratings are surveys of what our community members think about Fibrocell Science and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Fibrocell Science (NASDAQ:FCSC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.002.832.832.83
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.15$6.27$6.00$5.03
Price Target Upside: 136.75% upside107.51% upside84.05% upside105.44% upside

Fibrocell Science (NASDAQ:FCSC) Consensus Price Target History

Price Target History for Fibrocell Science (NASDAQ:FCSC)

Fibrocell Science (NASDAQ:FCSC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/5/2017HC WainwrightReiterated RatingBuy$7.60N/AView Rating Details
9/11/2017Canaccord GenuityReiterated RatingBuy$3.00 -> $7.00LowView Rating Details
3/7/2017Rodman & RenshawInitiated CoverageBuy -> Buy$2.00N/AView Rating Details
7/6/2016Griffin SecuritiesReiterated RatingBuy$12.00N/AView Rating Details
6/8/2016Roth CapitalReiterated RatingBuy$5.00N/AView Rating Details
6/8/2016WedbushReiterated RatingNeutral$1.50 -> $4.00N/AView Rating Details
(Data available from 12/12/2015 forward)

Earnings

Fibrocell Science (NASDAQ:FCSC) Earnings History and Estimates Chart

Earnings by Quarter for Fibrocell Science (NASDAQ:FCSC)

Fibrocell Science (NASDAQ FCSC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018($0.35)N/AView Earnings Details
8/9/2017Q2 2017($0.31)($0.31)ViewListenView Earnings Details
5/10/2017Q1 2017($0.29)($0.58)ViewN/AView Earnings Details
11/3/2016Q316($0.15)($0.05)$0.07 million$0.22 millionViewN/AView Earnings Details
3/10/2016Q415($0.17)($0.40)$0.07 million$0.08 millionViewListenView Earnings Details
11/5/2015Q315($0.16)($0.07)$0.06 million$0.08 millionViewN/AView Earnings Details
8/6/2015Q215($0.16)($0.17)$0.09 million$0.14 millionViewN/AView Earnings Details
5/8/2015Q1 2015($0.16)($0.17)$0.05 million$0.19 millionViewN/AView Earnings Details
3/13/2015Q4 2014($0.16)($0.16)$0.06 million$0.06 millionViewN/AView Earnings Details
11/7/2014Q3 14($0.14)($0.17)$0.06 million$0.02 millionViewN/AView Earnings Details
8/11/2014Q2 2014($0.18)($0.08)$0.07 million$0.06 millionViewN/AView Earnings Details
5/19/2014Q114($0.15)($0.35)$0.05 million$0.05 millionViewN/AView Earnings Details
3/17/2014Q414($0.26)($0.14)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Fibrocell Science (NASDAQ:FCSC) Earnings Estimates

2017 EPS Consensus Estimate: ($0.77)
2018 EPS Consensus Estimate: ($1.01)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174($0.31)($0.07)($0.19)
Q2 20174($0.34)($0.07)($0.20)
Q3 20174($0.35)($0.05)($0.20)
Q4 20173($0.37)($0.05)($0.20)
Q1 20181($0.26)($0.26)($0.26)
Q2 20181($0.29)($0.29)($0.29)
Q3 20181($0.23)($0.23)($0.23)
Q4 20181($0.23)($0.23)($0.23)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Fibrocell Science (NASDAQ:FCSC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Fibrocell Science (NASDAQ FCSC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 55.81%
Insider Trades by Quarter for Fibrocell Science (NASDAQ:FCSC)
Institutional Ownership by Quarter for Fibrocell Science (NASDAQ:FCSC)

Fibrocell Science (NASDAQ FCSC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2016David PernockChairmanBuy50,000$0.92$46,000.00View SEC Filing  
11/13/2015David PernockCEOBuy3,000$5.00$15,000.00View SEC Filing  
8/11/2015David PernockCEOBuy3,500$6.54$22,890.00View SEC Filing  
7/27/2015Randal J KirkMajor ShareholderBuy975,987$5.80$5,660,724.60View SEC Filing  
5/13/2015David PernockCEOBuy16,600$4.30$71,380.00View SEC Filing  
12/12/2014David PernockCEOBuy5,000$2.52$12,600.00View SEC Filing  
11/20/2014David PernockCEOBuy5,000$2.54$12,700.00View SEC Filing  
11/20/2014John Michael MaslowskiVPBuy1,000$2.54$2,540.00View SEC Filing  
6/5/2014Christine St.ClareDirectorBuy10,000$3.00$30,000.00View SEC Filing  
6/5/2014David PernockCEOBuy12,500$2.95$36,875.00View SEC Filing  
6/4/2014Kelvin MooreDirectorBuy4,557$2.99$13,625.43View SEC Filing  
6/4/2014Randal J KirkMajor ShareholderBuy400,000$2.90$1,160,000.00View SEC Filing  
1/24/2014Randal J KirkMajor ShareholderBuy1,024,590$4.88$4,999,999.20View SEC Filing  
11/21/2013David PernockCEOBuy10,000$3.69$36,900.00View SEC Filing  
11/20/2013Gregory L WeaverCFOBuy10,000$3.51$35,100.00View SEC Filing  
10/1/2013Randal J KirkMajor ShareholderBuy3,658,536$4.10$14,999,997.60View SEC Filing  
7/26/2013Randal J KirkMajor ShareholderBuy1,243,781$6.03$7,499,999.43View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Fibrocell Science (NASDAQ FCSC) News Headlines

Source:
DateHeadline
Should You Worry About Fibrocell Science Inc’s (FCSC) CEO Pay Check?Should You Worry About Fibrocell Science Inc’s (FCSC) CEO Pay Check?
finance.yahoo.com - December 9 at 9:42 AM
Fibrocell Science Inc (FCSC) Feels the Heat of Share DilutionFibrocell Science Inc (FCSC) Feels the Heat of Share Dilution
finance.yahoo.com - December 7 at 5:35 PM
Fibrocell Announces Pricing of $10.5 Million Underwritten Public OfferingFibrocell Announces Pricing of $10.5 Million Underwritten Public Offering
finance.yahoo.com - December 7 at 9:57 AM
Was Fibrocell Science Inc’s (FCSC) Earnings Growth Better Than Industry?Was Fibrocell Science Inc’s (FCSC) Earnings Growth Better Than Industry?
finance.yahoo.com - November 30 at 10:08 AM
Short Interest in Fibrocell Science Inc (FCSC) Rises By 43.3%Short Interest in Fibrocell Science Inc (FCSC) Rises By 43.3%
www.americanbankingnews.com - November 29 at 2:08 AM
Head-To-Head Analysis: Fibrocell Science (FCSC) vs. Roka Bioscience (ROKA)Head-To-Head Analysis: Fibrocell Science (FCSC) vs. Roka Bioscience (ROKA)
www.americanbankingnews.com - November 27 at 3:18 AM
Fibrocell Reports Third Quarter 2017 Financial Results and Recent Highlights - GlobeNewswire (press release)Fibrocell Reports Third Quarter 2017 Financial Results and Recent Highlights - GlobeNewswire (press release)
globenewswire.com - November 14 at 7:00 PM
Fibrocell Sciences (FCSC) CEO John Maslowski on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaFibrocell Science's (FCSC) CEO John Maslowski on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 14 at 7:00 PM
Fibrocell Science Inc (FCSC) Issues Quarterly  Earnings ResultsFibrocell Science Inc (FCSC) Issues Quarterly Earnings Results
www.americanbankingnews.com - November 13 at 11:30 AM
Fibrocell Science, Inc. to Host Earnings CallFibrocell Science, Inc. to Host Earnings Call
finance.yahoo.com - November 13 at 10:12 AM
Fibrocell Reports Third Quarter 2017 Financial Results and Recent HighlightsFibrocell Reports Third Quarter 2017 Financial Results and Recent Highlights
finance.yahoo.com - November 13 at 10:12 AM
Fibrocell Science reports 3Q lossFibrocell Science reports 3Q loss
finance.yahoo.com - November 13 at 10:12 AM
Intrexon (XON) Q3 Loss Narrower Than Expected, Revenues Miss - NasdaqIntrexon (XON) Q3 Loss Narrower Than Expected, Revenues Miss - Nasdaq
www.nasdaq.com - November 11 at 8:33 AM
Pre-Market Earnings Report for November 13, 2017 : JD, TSN, ACM, ABY, VRAY, KMDA, PTN, ASUR, RDHL, CYRN ... - NasdaqPre-Market Earnings Report for November 13, 2017 : JD, TSN, ACM, ABY, VRAY, KMDA, PTN, ASUR, RDHL, CYRN ... - Nasdaq
www.nasdaq.com - November 11 at 8:33 AM
Comparing Fibrocell Science (FCSC) & ANI Pharmaceuticals (ANIP)Comparing Fibrocell Science (FCSC) & ANI Pharmaceuticals (ANIP)
www.americanbankingnews.com - November 11 at 5:48 AM
Intrexon (XON) Q3 Loss Narrower Than Expected, Revenues MissIntrexon (XON) Q3 Loss Narrower Than Expected, Revenues Miss
finance.yahoo.com - November 10 at 3:00 PM
New Skin for 7-Year-Old Boy Marks Advance in Gene TherapyNew Skin for 7-Year-Old Boy Marks Advance in Gene Therapy
finance.yahoo.com - November 9 at 3:15 AM
Fibrocell Science Inc (FCSC) Scheduled to Post Quarterly Earnings on MondayFibrocell Science Inc (FCSC) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - November 7 at 10:08 AM
Fibrocell to Host Conference Call and Webcast on Monday, November 13, 2017 to Discuss Third Quarter 2017 ... - GlobeNewswire (press release)Fibrocell to Host Conference Call and Webcast on Monday, November 13, 2017 to Discuss Third Quarter 2017 ... - GlobeNewswire (press release)
globenewswire.com - November 6 at 8:23 PM
Fibrocell to Host Conference Call and Webcast on Monday, November 13, 2017 to Discuss Third Quarter 2017 Financial Results and Recent Operational HighlightsFibrocell to Host Conference Call and Webcast on Monday, November 13, 2017 to Discuss Third Quarter 2017 Financial Results and Recent Operational Highlights
finance.yahoo.com - November 6 at 8:23 PM
Whats in Store for Intrexon (XON) This Earnings Season? - NasdaqWhat's in Store for Intrexon (XON) This Earnings Season? - Nasdaq
www.nasdaq.com - October 31 at 7:48 PM
What's in Store for Intrexon (XON) This Earnings Season?What's in Store for Intrexon (XON) This Earnings Season?
finance.yahoo.com - October 31 at 7:48 PM
Reviewing NovaBay Pharmaceuticals (NBY) & Fibrocell Science (FCSC)Reviewing NovaBay Pharmaceuticals (NBY) & Fibrocell Science (FCSC)
www.americanbankingnews.com - October 20 at 6:46 AM
Fibrocell Science: A Very Appealing Gene Therapy Play - Seeking AlphaFibrocell Science: A Very Appealing Gene Therapy Play - Seeking Alpha
seekingalpha.com - October 19 at 7:21 PM
Fibrocell Science Inc (FCSC) Upgraded to Hold at Zacks Investment ResearchFibrocell Science Inc (FCSC) Upgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - October 10 at 7:40 PM
Fibrocell Science Inc (FCSC) Receives Buy Rating from HC WainwrightFibrocell Science Inc (FCSC) Receives Buy Rating from HC Wainwright
www.americanbankingnews.com - October 5 at 10:08 AM
 Brokerages Anticipate Fibrocell Science Inc (FCSC) to Announce -$0.41 Earnings Per Share Brokerages Anticipate Fibrocell Science Inc (FCSC) to Announce -$0.41 Earnings Per Share
www.americanbankingnews.com - October 4 at 6:26 PM
Fibrocell to Present at 2017 Cell & Gene Meeting on the MesaFibrocell to Present at 2017 Cell & Gene Meeting on the Mesa
finance.yahoo.com - October 2 at 7:39 PM
HC Wainwright Raises Fibrocell Science Inc (FCSC) Price Target to $7.60HC Wainwright Raises Fibrocell Science Inc (FCSC) Price Target to $7.60
www.americanbankingnews.com - September 26 at 11:18 AM
Fibrocell Science (FCSC) vs. Its Competitors Head to Head ContrastFibrocell Science (FCSC) vs. Its Competitors Head to Head Contrast
www.americanbankingnews.com - September 25 at 12:26 AM
Implied Volatility Surging for Fibrocell Science (FCSC) Stock Options - NasdaqImplied Volatility Surging for Fibrocell Science (FCSC) Stock Options - Nasdaq
www.nasdaq.com - September 24 at 4:15 AM
Implied Volatility Surging for Fibrocell Science (FCSC) Stock OptionsImplied Volatility Surging for Fibrocell Science (FCSC) Stock Options
finance.yahoo.com - September 23 at 9:44 AM
Fibrocell Science Inc (FCSC) Stock Rating Reaffirmed by Canaccord GenuityFibrocell Science Inc (FCSC) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - September 17 at 10:22 PM
 Analysts Expect Fibrocell Science Inc (FCSC) to Post -$0.41 Earnings Per Share Analysts Expect Fibrocell Science Inc (FCSC) to Post -$0.41 Earnings Per Share
www.americanbankingnews.com - September 16 at 12:08 AM
Fibrocell Science Inc (FCSC) Coverage Initiated by Analysts at HC WainwrightFibrocell Science Inc (FCSC) Coverage Initiated by Analysts at HC Wainwright
www.americanbankingnews.com - September 15 at 7:28 AM
Fibrocell Science (FCSC) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - SlideshowFibrocell Science (FCSC) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 11 at 7:09 PM
10 Biggest Mid-Day Gainers For Friday - Benzinga10 Biggest Mid-Day Gainers For Friday - Benzinga
www.benzinga.com - September 8 at 7:03 PM
Fibrocell to Present at Rodman & Renshaw 19th Annual Global Investment Conference and Global Genes’ 2017 RARE Patient Advocacy SummitFibrocell to Present at Rodman & Renshaw 19th Annual Global Investment Conference and Global Genes’ 2017 RARE Patient Advocacy Summit
finance.yahoo.com - September 5 at 8:14 PM
Brokers Offer Predictions for Fibrocell Science Incs Q1 2018 Earnings (FCSC)Brokers Offer Predictions for Fibrocell Science Inc's Q1 2018 Earnings (FCSC)
www.americanbankingnews.com - August 14 at 6:58 AM
Fibrocell Science Inc (NASDAQ:FCSC) Posts Quarterly  Earnings Results, Meets ExpectationsFibrocell Science Inc (NASDAQ:FCSC) Posts Quarterly Earnings Results, Meets Expectations
www.americanbankingnews.com - August 11 at 2:06 PM
 Analysts Anticipate Fibrocell Science Inc (NASDAQ:FCSC) to Post -$0.31 EPS Analysts Anticipate Fibrocell Science Inc (NASDAQ:FCSC) to Post -$0.31 EPS
www.americanbankingnews.com - August 10 at 8:06 AM
Fibrocell Reports Second Quarter 2017 Financial Results and Recent HighlightsFibrocell Reports Second Quarter 2017 Financial Results and Recent Highlights
finance.yahoo.com - August 9 at 6:47 PM
Fibrocell Science reports 2Q lossFibrocell Science reports 2Q loss
finance.yahoo.com - August 9 at 6:46 PM
Fibrocell to Present at Canaccord Genuity 37th Annual Growth ConferenceFibrocell to Present at Canaccord Genuity 37th Annual Growth Conference
finance.yahoo.com - August 3 at 3:40 PM
Fibrocell Science Inc (NASDAQ:FCSC) Set to Announce Earnings on WednesdayFibrocell Science Inc (NASDAQ:FCSC) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - August 3 at 10:58 AM
Whats in Store for Intrexon (XON) in this Earnings Season?What's in Store for Intrexon (XON) in this Earnings Season?
www.zacks.com - August 2 at 7:29 PM
Fibrocell to Host Conference Call and Webcast on Wednesday, August 9, 2017 to Discuss Second Quarter 2017 Financial Results and Recent Operational HighlightsFibrocell to Host Conference Call and Webcast on Wednesday, August 9, 2017 to Discuss Second Quarter 2017 Financial Results and Recent Operational Highlights
finance.yahoo.com - August 2 at 7:29 PM
What's in Store for Intrexon (XON) in this Earnings Season?What's in Store for Intrexon (XON) in this Earnings Season?
finance.yahoo.com - August 2 at 7:29 PM
-$0.31 EPS Expected for Fibrocell Science Inc (NASDAQ:FCSC) This Quarter-$0.31 EPS Expected for Fibrocell Science Inc (NASDAQ:FCSC) This Quarter
www.americanbankingnews.com - July 20 at 10:15 PM
XLRNs DART Misses Mark, RGLS Makes Cuts In Pipeline, FDA Snubs CHRSXLRN's DART Misses Mark, RGLS Makes Cuts In Pipeline, FDA Snubs CHRS
www.rttnews.com - June 13 at 11:33 AM

SEC Filings

Fibrocell Science (NASDAQ:FCSC) SEC Filings

DateFilerForm TypeView
12/11/2017
4:20 PM
Fibrocell Science (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/08/2017
4:13 PM
Fibrocell Science (Filer)
Form 424B4
View Filing
12/06/2017
11:15 PM
Fibrocell Science (Filer)
Form EFFECT
View Filing
12/05/2017
7:47 PM
Fibrocell Science (Filer)
Form S-1/A
View Filing
12/04/2017
4:09 PM
Fibrocell Science (Filer)
Form S-1/A
View Filing

Social Media

Financials

Fibrocell Science (NASDAQ:FCSC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Fibrocell Science (NASDAQ FCSC) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.